Who got AIG's bailout billions?

Sun Mar 8, 2009 8:30am EDT
 
[-] Text [+]

TOXIC ASSETS/TOXIC WASTE

As part of its business, AIG insured counterparties on mortgage-backed securities and other assets. The collapse of the U.S. subprime mortgage market, which triggered a global financial crisis, left the insurer and some of its policy holders facing possible ruin as the value of assets declined.

U.S. regulators failed to recognize how much risk AIG was piling on in credit-default swaps, and by the time they understood, they had no choice but to pour in billions of public dollars, Kohn and other officials told the Senate panel.

Senators were outraged by the lack of details about where the bailout money has gone.

"That we find ourselves in this situation at all is ... quite frankly, sickening," said Senator Christopher Dodd, the Democrat who chairs the committee. "The lack of transparency and accountability in this process has been rather stunning."

Eric Dinallo, superintendent of New York State's Insurance Department, railed on Friday against AIG's failed business model, likening its insuring credit-default swaps as gambling with somebody else's money.

"It's like taking insurance on your neighbor's house and even maybe contributing to blowing it up," he said at a panel sponsored by New York University's Stern School of Business.

U.S. lawmakers have said they are running out of patience with regulators' refusal to identify AIG's counterparties.

On Thursday, Richard Shelby, the top Republican on the banking committee, said: "The Fed and Treasury can be secretive for a while but not forever."

(Writing Toni Reinhold; Additional reporting by Juan Lagorio in New York; Editing by Clive McKeef)

 
Photo

Editor's Choice

A selection of our best photos from the past 24 hours.  Slideshow 

Most Popular on Reuters

  • Articles
  • Video
A radiologist examines breast X-rays at the Ambroise Pare hospital in Marseille, April 3, 2008.   REUTERS/Jean-Paul Pelissier
Burden of proof: Breast cancer changes fall short

Making drastic changes to U.S. breast cancer screening guidelines will take much stronger evidence than that offered by a federal advisory panel this week, U.S. doctors said.  Full Article